0001144204-16-091531.txt : 20160330 0001144204-16-091531.hdr.sgml : 20160330 20160330162937 ACCESSION NUMBER: 0001144204-16-091531 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160330 DATE AS OF CHANGE: 20160330 EFFECTIVENESS DATE: 20160330 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Epica International, Inc. CENTRAL INDEX KEY: 0001627509 IRS NUMBER: 464501815 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-260325 FILM NUMBER: 161540058 BUSINESS ADDRESS: STREET 1: 2753 CAMINO CAPISTRANO STREET 2: SUITE A-101 CITY: SAN CLEMENTE STATE: CA ZIP: 92672 BUSINESS PHONE: 9492386323 MAIL ADDRESS: STREET 1: 2753 CAMINO CAPISTRANO STREET 2: SUITE A-101 CITY: SAN CLEMENTE STATE: CA ZIP: 92672 D 1 primary_doc.xml X0707 D LIVE 0001627509 Epica International, Inc. 2753 CAMINO CAPISTRANO SUITE A-101 SAN CLEMENTE CA CALIFORNIA 92672 9492386323 NEVADA None None Corporation true 2013 Gregory Stoutenburgh 2753 Camino Capistrano, Suite A-101 San Clemente CA CALIFORNIA 92672 Executive Officer Director Chief Executive Officer and Chairman Damiano Fortuna 2753 Camino Capistrano, Suite A-101 San Clemente CA CALIFORNIA 92672 Director Eric Lindquist 2753 Camino Capistrano, Suite A-101 San Clemente CA CALIFORNIA 92672 Executive Officer Director Chief Medical Officer Philip Warth 2753 Camino Capistrano, Suite A-101 San Clemente CA CALIFORNIA 92672 Director Michael Fajardo 2753 Camino Capistrano, Suite A-101 San Clemente CA CALIFORNIA 92672 Executive Officer Director Chief Financial Officer Renzo Valleggi 2753 Camino Capistrano, Suite A-101 San Clemente CA CALIFORNIA 92672 Executive Officer Director Chief Technology Officer Thomas Grossman 2753 Camino Capistrano, Suite A-101 San Clemente CA CALIFORNIA 92672 Director Jerry Sherlock 2753 Camino Capistrano, Suite A-101 San Clemente CA CALIFORNIA 92672 Executive Officer Chief Operations Officer Other Health Care Decline to Disclose 06b false 2016-03-21 false true false 9999 PHX Financial, Inc. 144403 None None 100 WALL STREET, 10TH FLOOR NEW YORK NY NEW YORK 10005 All States false 2999997 85421 2914576 false 3 390000 true 0 PHX will receive a cash commission and a non-accountable expense equal to 10% and 3%, respectively, of the aggregate gross proceeds. PHX will also receive warrants to purchase shares of common stock equal to 10% of the total number of shares issued. 0 false Epica International, Inc. /s/ Gregory Stoutenburgh Gregory Stoutenburgh CEO and Chairman 2016-03-30